Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 22;21(1):189.
doi: 10.1186/s12957-023-03061-2.

Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis

Benedikt Hoeh #  1 , Mike Wenzel #  2   3 , Olivia Eckart  2 , Felicia Fleisgarten  2 , Cristina Cano Garcia  2   4 , Jens Köllermann  5 , Christoph Würnschimmel  3   6 , Alessandro Larcher  3   7 , Pierre Karakiewicz  4 , Luis A Kluth  2 , Felix K H Chun  2 , Philipp Mandel  2 , Andreas Becker  2
Affiliations

Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis

Benedikt Hoeh et al. World J Surg Oncol. .

Abstract

Background: Partial nephrectomy (PN) is the gold standard surgical treatment for resectable renal cell carcinoma (RCC) tumors. However, the decision whether a robotic (RAPN) or open PN (OPN) approach is chosen is often based on the surgeon's individual experience and preference. To overcome the inherent selection bias when comparing peri- and postoperative outcomes of RAPN vs. OPN, a strict statistical methodology is needed.

Materials and methods: We relied on an institutional tertiary-care database to identify RCC patients treated with RAPN and OPN between January 2003 and January 2021. Study endpoints were estimated blood loss (EBL), length of stay (LOS), rate of intraoperative and postoperative complications, and trifecta. In the first step of analyses, descriptive statistics and multivariable regression models (MVA) were applied. In the second step of analyses, to validate initial findings, MVA were applied after 2:1 propensity-score matching (PSM).

Results: Of 615 RCC patients, 481 (78%) underwent OPN vs 134 (22%) RAPN. RAPN patients were younger and presented with a smaller tumor diameter and lower RENAL-Score sum, respectively. Median EBL was comparable, whereas LOS was shorter in RAPN vs. OPN. Both intraoperative (27 vs 6%) and Clavien-Dindo > 2 complications (11 vs 3%) were higher in OPN (both < 0.05), whereas achievement of trifecta was higher in RAPN (65 vs 54%; p = 0.028). In MVA, RAPN was a significant predictor for shorter LOS, lower rates of intraoperative and postoperative complications as well as higher trifecta rates. After 2:1 PSM with subsequent MVA, RAPN remained a statistical and clinical predictor for lower rates of intraoperative and postoperative complications and higher rates of trifecta achievement but not LOS.

Conclusions: Differences in baseline and outcome characteristics exist between RAPN vs. OPN, probably due to selection bias. However, after applying two sets of statistical analyses, RAPN seems to be associated with more favorable outcomes regarding complications and trifecta rates.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Ljungberg B, Albiges L, Bensalah K et al. EAU guidelines on renal cell carcinoma. 2020. EAU Guidelines Office, Arnhem, The Netherlands. http://uroweb.org/guidelines/compilations-of-all-guidelines/.
    1. Wenzel M, Yu H, Uhlig A, et al. Cystatin C predicts renal function impairment after partial or radical tumor nephrectomy. Int Urol Nephrol. 2021;53(10):2041–2049. doi: 10.1007/s11255-021-02957-w. - DOI - PMC - PubMed
    1. Wenzel M, Kleimaker A, Uhlig A, et al. Impact of comorbidities on acute kidney injury and renal function impairment after partial and radical tumor nephrectomy. Scand J Urol. 2021;55(5):377–382. doi: 10.1080/21681805.2021.1948916. - DOI - PubMed
    1. Hung AJ, Cai J, Simmons MN, Gill IS. “Trifecta” in partial nephrectomy. J Urol. 2013;189(1):36–42. doi: 10.1016/j.juro.2012.09.042. - DOI - PubMed
    1. Nocera L, Collà Ruvolo C, Stolzenbach LF, et al. Tumor stage and substage predict cancer-specific mortality after nephrectomy for nonmetastatic renal cancer: histological subtype-specific validation. Eur Urol Focus. Published online February 27, 2021. 10.1016/j.euf.2021.02.009. - PubMed

MeSH terms